We have 3 of 18 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Lipid Nanoparticles Based Multi-Scale Systemic Immune Programming for Cancer Therapy.
A dual-track therapeutic paradigm that integrates tumor-directed immune activation with host physiological restoration is proposed, which positions LNP-based therapies to treat cancer as a systemic immune-metabolic disorder rather than a localized disease.
Nonviral delivery of chemically modified tRNA rescues nonsense mutations in cystic fibrosis.
This work combined site-specific chemical modification of sup-tRNAs with cargo-tailored pulmonary lipid nanoparticle (LNP) engineering to overcome barriers and restore cystic fibrosis transmembrane conductance regulator (CFTR) expression and function.